May 2024 Tender Notification

Medicines Tender Closed

Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2022/23 Invitation to Tender, dated 31 October 2022 and in the 2023/24 Invitation to Tender dated 31 October 2023.

Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceutical under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:

  • For new listings, by 4pm on the 12th of June 2024 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website

Process for notification of product changes (NOPC)

Suppliers are required to ensure that a Pharmacode(external link) has been obtained from the Pharmacy Guild of New Zealand and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link)

Pharmacodes and CTPP codes must be provided to Pharmac by the fifth of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode.

2022/23 Tender – Principal Supply Status applies until 30 June 2026

Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule

The decisions were as follows:

1. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

Listing date

Principal Supply date

Brand (Supplier) affected by delisting

Metronidazole

Tab 200 mg; 250 tablet bottle pack

$33.15

$25.86

Metromed (Medsurge)

1 October 2024

1 March 2025

Metrogyl (Viatris)

Metronidazole

Tab 400 mg; 21 tablet blister pack

$5.23

$4.29

Metromed (Medsurge)

1 October 2024

1 March 2025

Metrogyl (Viatris)

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

DV limit

Listing date

Principal Supply date

Brand (Supplier) affected by delisting

Metronidazole

Tab 200 mg; 250 tablet bottle pack

$33.15

$25.86

Metromed (Medsurge)

5%

1 October 2024

1 March 2025

Metrogyl (Viatris)

Metronidazole

Tab 400 mg; 21 tablet blister pack

$5.23

$4.29

Metromed (Medsurge)

5%

1 October 2024

1 March 2025

Metrogyl (Viatris)

2023/24 Tender – Principal Supply Status applies until 30 June 2027

Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule

The decisions were as follows:

3. Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

Date of subsidy change

Principal Supply date

Brand (Supplier) affected by delisting

Aqueous cream

Crm; 500 g tub

$1.73

$1.65

Evara (Evara)

1 October 2024

1 March 2025

GEM Aqueous Cream (BioInnova)

healthE Aqueous Cream SLS Free (Jaychem)

Baclofen

Inj 2 mg per ml, 5 ml ampoule; 10 ampoule pack

$306.82

(5 pack)

$490.91

Baclofen Sintetica (Boucher)

1 October 2024

1 March 2025

Medsurge (Medsurge)

Clonidine hydrochloride

Inj 150 mcg per ml, 1 ml ampoule; 5 ampoule pack

$29.68
(10 pack)

$14.10

Catapres (Clinect)

1 August 2024

1 January 2025

Clonidine HCL-Medsurge (Medsurge)

Entacapone

Tab 200 mg; 100 tablet bottle pack

$18.04

$13.73

Entapone (Viatris)

1 February 2025

1 July 2025

Comtan (Max Health)

Modafinil1

Tab 100 mg; 30 tablet blister pack

$29.13

(60 pack)

$14.27

Modafinil (Max Health)

1 December 2024

1 May 2025

Modavigil (Teva)

1Brand Switch Fee of $4.50 is payable for this product from 1 May 2025 until 1 September 2025.

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.

4. Tenders awarded pharmaceuticals where no other brand is listed.

Chemical name

Presentation;
Pack size and type

Pack price

Principal Supply brand
(Supplier)

DV Limit

Listing date

Principal Supply date

Aqueous Cream

Crm; 100 g tube

$1.25

Evara (Evara)

5%

1 October 2024

1 March 2025

5. Tenders awarded pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand
(Supplier)

DV Limit

Listing date

Principal Supply date

Brand (Supplier) affected by delisting

Aqueous Cream

Crm; 500 g tub

$1.73

$1.65

Evara (Evara)

5%

1 October 2024

1 March 2025

GEM Aqueous Cream (BioInnova)

Baclofen

Inj 2 mg per ml, 5 ml ampoule; 10 ampoule pack

$306.82

(5 pack)

$490.91

Baclofen Sintetica (Boucher)

5%

1 October 2024

1 March 2025

Medsurge (Medsurge)

Clonidine hydrochloride

Inj 150 mcg per ml, 1 ml ampoule; 5 ampoule pack

$29.68
(10 pack)

$14.10

Catapres (Clinect)

5%

1 August 2024

1 January 2025

Clonidine HCL-Medsurge (Medsurge)

Entacapone

Tab 200 mg; 100 tablet bottle pack

$18.04

$13.73

Entapone (Viatris)

5%

1 February 2025

1 July 2025

Comtan (Max Health)

Flumazenil

Inj 0.1 mg per ml, 5 ml ampoule; 5 ampoule pack size

$110.12

(10 pack)

$44.00

Flumazenil-Baxter (Baxter)

5%

1 July 2024

1 December 2024

Hameln (Max Health)

Modafinil

Tab 100 mg; 30 tablet blister pack

$29.13

(60 pack)

$14.27

Modafinil (Max Health)

5%

1 December 2024

1 May 2025

Modavigil (Teva)

Terlipressin

Inj 0.2 mg per ml, 5 ml vial; 5 vial pack

$215.00

$110.00

Terlipressin Ever Pharma (InterPharma)

5%

1 September 2024

1 February 2025

Glypressin (Pharmaco)

Tender declines – Products where no tender is to be awarded for Principal Supply Status

Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2023/24 Invitation to Tender, dated 31 October 2023.

Chemical Name

Line Item

Benzylpenicillin sodium

Inj 1.2 g

Benzylpenicillin sodium

Inj 3 g

Epirubicin

Inj 2 mg per ml, 100 ml

Epirubicin

Inj 2 mg per ml, 25 ml

Epirubicin

Inj 2 mg per ml, 5 ml

Glyceryl Trinitrate

Oint 0.2%

Sodium citrate

Oral liq 8.8 % (300 mmol/l)

 

 

 

 

 

 

 

 

 

 

 

For products included in the 2022/23 and 2023/24 Invitation to Tender where no announcement has yet been made, a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.